Your search returned 2 results.

Results
	1.	Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group. [electronic resource] by Garcia-Alfonso, P Muñoz-Martin, A Mendez-Ureña, M Quiben-Pereira, R Gonzalez-Flores, E Perez-Manga, G Producer: 20091014 In: British journal of cancer vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study. [electronic resource] by Aranda, E García-Alfonso, P Benavides, M Sánchez Ruiz, A Guillén-Ponce, C Safont, M J Alcaide, J Gómez, A López, R Manzano, J L Méndez Ureña, M Sastre, J Rivera, F Grávalos, C García, T Martín-Valadés, J I Falcó, E Navalón, M González Flores, E Ma García Tapiador, A Ma López Muñoz, A Barrajón, E Reboredo, M García Teijido, P Viudez, A Cárdenas, N Díaz-Rubio, E Producer: 20190415 In: European journal of cancer (Oxford, England : 1990) vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search